Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $19.

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q4 CY2024, but ...

LAHORE: The University of Health Sciences (UHS) Lahore is all set to inaugurate its state-of-the-art diagnostic laboratory on ...

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal ...

The global personalized medicine market size is calculated at USD 620.13 billion in 2025 and is expected to reach around USD ...

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger trend? He found his answer after sifting through national health data: ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

The University of Toronto has launched a rapid research response to address the public health risk posed by highly pathogenic avian influenza ...

Scientists have uncovered a fascinating piece of the puzzle surrounding the origins of human language, suggesting that a ...

Every day a child in Romania is diagnosed with cancer. Every day a family in our country enters the battle with a disease ...